The biotechnological company ADmit Therapeutics, member of CATALONIA.HEALTH, receives an accreditation from the Accreditation Committee of the College of American Pathologists (CAP), based on results of a recent on-site inspection as part of the CAP’s Accreditation Programs.
Recognized for rigorous and robust standards, CAP accreditation elevates quality and mitigates risk, an important way that laboratories can contribute to improved patient outcomes. ADmit Therapeutics is one of more than 8,000 CAP-accredited facilities worldwide. The CAP offers proficiency testing/external quality assessment (PT/EQA) programs, quality improvement tools, and protocols and guidelines to ensure excellence in all areas across the laboratory.
Upon learning of the laboratory’s accreditation Marta Barrachina, CEO of ADmit Therapeutics, said: “This accreditation verifies the accuracy and reliability of our entire testing process and demonstrates the huge effort done by our team. I would like to highlight the excellent work of our Quality Manager, Victor Fuentes, and our Laboratory Director, Marta Blanch. Moreover, we are very proud of becoming the first CAP-accredited laboratory in Spain”.
Related news:
ADmit therapeutics closes a €5.4 million funding round (6 October 2023)
Comments